Comparative study to see the effect of magnesium sulphate as an agent to reduced pain when given via spinal anaesthesia or intravenous routes in patients for hip surgery.
Phase 3
Completed
- Conditions
- Health Condition 1: null- Extracapsular hip fracture patients
- Registration Number
- CTRI/2015/06/005923
- Lead Sponsor
- Department of pharmacology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
ASA physical classIandII.
BMI 18.5-39.9
Patients undergoing extracapsular hip surgeries under subarachnoid block
Exclusion Criteria
BMI > 40.
Absolute contraindications for spinal anaesthesia.
Uncontrolled and labile hypertension.
Allergic to any of the study drugs.
Patients refusal for spinal anaesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the analgesic efficacy with magnesium sulphate <br/ ><br>using intravenous and intrathecal routes.Timepoint: To compare the analgesic efficacy with magnesium sulphate <br/ ><br>using intravenous and intrathecal routes.
- Secondary Outcome Measures
Name Time Method To compare the haemodynamic stability in the form of non-invasive BP, Heart rate, SpO2 intraoperatively and post-operatively.Timepoint: Intra-operative monitoring at Base line and then every 1 min up to 10 min,then every 5 min upto 40 min, then every 10 min <br/ ><br>upto 60 min,then every 15 min upto 120 min,then every 30 min <br/ ><br>upto 360 min or till then the surgery over.o hour is taken as the time when the patient was shifted to recovery.The patient is followed at 0hr, 1hr,2hr,3hr,4hr,5hr,6hr,8hr,10 hr,12 hr, 15hr, 18 hr and 24 hr after the surgery.